18,587 articles
John E. Mullet
John E. Mullet is a University Distinguished Professor at Texas A&M University known for chloroplast gene expression, jasmonate signaling in plant defense, and sorghum genomics for bioenergy crops.
John E. Nestler
John E. Nestler is an American endocrinologist and physician-scientist at Virginia Commonwealth University in Richmond, known for establishing insulin resistance as central to polycystic ovary syndrome and for metformin trials.
John E. Niederhuber
John E. Niederhuber is an American surgical oncologist who served as the 13th director of the National Cancer Institute from 2006 to 2010 and pioneered implantable chemotherapy devices.
John E. Smart
John E. Smart is a molecular biologist trained at Caltech who worked on polyoma tumor antigens and the adenovirus terminal protein at Cold Spring Harbor and Biogen.
John E. Sulston
John E. Sulston (1942–2018) was a British geneticist who mapped the roundworm cell lineage, directed the Sanger Centre, and shared the 2002 Nobel Prize in Medicine.
John E. Wagner
John E. Wagner is an American pediatric hematologist-oncologist at the University of Minnesota whose work made umbilical cord blood a standard alternative to matched bone marrow donors.
John E. Walker
John E. Walker, born in 1941, is a British biochemist at Cambridge who determined the structure of ATP synthase and shared the 1997 Nobel Prize in Chemistry.
John E. Wennberg
John E. Wennberg (1935–2024) was an American health services researcher at Dartmouth College who pioneered the study of small area variations in health care delivery.
John E.J. Rasko
John E.J. Rasko is an Australian clinical haematologist and molecular biologist who led Australia's first clinical gene therapy program and ran world-first trials for hemophilia and thalassaemia.
John Eccles (neurophysiologist)
Sir John Carew Eccles (1903–1997) was an Australian neurophysiologist who shared the 1963 Nobel Prize in Physiology or Medicine for establishing that synapses transmit signals chemically.
John Edwards Holbrook
John Edwards Holbrook (1794–1871) was an American physician and zoologist of Charleston, South Carolina, best known for North American Herpetology, the first comprehensive work on North American reptiles and amphibians.
John F. Atkins
John F. Atkins (John Fuller Atkins), born 1944, is an Irish molecular geneticist at University College Cork known for establishing recoding, the reprogramming of genetic decoding by mRNA signals.
John F. Cryan
John F. Cryan is an Irish neuroscientist, Professor and Chair of Anatomy and Neuroscience at University College Cork, known for research on the microbiome-gut-brain axis in stress and psychiatric disorders.
John F. DiPersio
John F. DiPersio is an American hematologist-oncologist and stem cell biologist at Washington University School of Medicine in St. Louis, known for developing plerixafor and motixafortide.
John F. Enders
John F. Enders (1897–1985) was an American virologist at Harvard and Boston Children's Hospital who shared the 1954 Nobel Prize for growing polio virus in tissue culture, enabling the Salk and Sabin vaccines.
John F. Engelhardt
John F. Engelhardt is an American molecular geneticist known for cystic fibrosis lung biology and gene therapy, especially genetically engineered ferret models of the disease.
John F. Keaney
John F. Keaney is an American cardiologist who leads Cardiovascular Medicine at Brigham and Women's Hospital and studies how blood vessels resist injury from cholesterol, blood pressure, and diabetes.
John F. Kearney
John F. Kearney (born 1945) is an Australian-born immunologist and Professor Emeritus at the University of Alabama at Birmingham, known for research on B cell development and natural antibodies.
John F. Marko
John F. Marko is a biological physicist and Northwestern University professor known for work on DNA supercoiling, DNA elasticity, and chromosome organization by loop extrusion.
John F. Tisdale
John F. Tisdale, also known as John Tisdale, is an American physician-scientist who chief of the Cellular and Molecular Therapeutics Branch at NIH, developing cures for sickle cell disease.
John Farquhar Fulton
John Farquhar Fulton (1899–1960) was an American neurophysiologist and historian of medicine who built the first primate physiology laboratory in the United States at Yale, co-founded the Journal of Neurosurgery, and co-founded Yale's medical-historical library.
John Forssman
John Forssman (1868–1947) was a Swedish bacteriologist and pathologist at Lund University who discovered the heterophile Forssman antigen in 1911 and was nominated for the 1938 Nobel Prize.
John G. Bartlett
John G. Bartlett (1937–2021) was an American infectious-disease physician who led Johns Hopkins' division from 1980 to 2006 and identified Clostridium difficile as the cause of antibiotic-associated colitis.
John G. Doench
John G. Doench, also cited as John Doench, directs research at the Broad Institute's Genetic Perturbation Platform and is known for sgRNA design rules for CRISPR-Cas9.
John G. Flanagan
John G. Flanagan is an optometrist and glaucoma researcher who served as inaugural dean of the Herbert Wertheim School of Optometry at UC Berkeley from 2014 to 2025.
John G. Gorman
John G. Gorman, born 1931, is an Australian-born hematologist who, with Vincent Freda and William Pollack at Columbia University, developed RhoGAM, the anti-D injection preventing Rh disease in newborns, sharing the 1980 Lasker Award.
John G. Haddad
John G. Haddad (1937–1997) was an American endocrinologist at the University of Pennsylvania who developed the first reliable blood test for vitamin D and led its endocrinology division.
John G. Kelton
John G. Kelton is a Canadian hematologist and physician-scientist at McMaster University whose research on heparin-induced thrombocytopenia and immune thrombocytopenia changed treatment worldwide; he was elected to the Royal Society of Canada in 2002.
John G. Laffey
John G. Laffey is an Irish anesthesiologist, Professor of Anaesthesia and Intensive Care Medicine at the University of Galway, known for research on carbon dioxide biology and ARDS.
John G. McHutchison
John G. McHutchison is an Australian-born hepatologist and clinical trialist whose trials transformed hepatitis C into a curable disease; he has led Tune Therapeutics as CEO since March 2025.